Targeting glycolysis in leukemia: a novel inhibitor 3-BrOP in combination with rapamycin
about
Metabolic interplay between glycolysis and mitochondrial oxidation: The reverse Warburg effect and its therapeutic implicationTargeting the PI3K/AKT/mTOR signaling axis in children with hematologic malignanciesSIRT2 activates G6PD to enhance NADPH production and promote leukaemia cell proliferationAscorbic acid and a cytostatic inhibitor of glycolysis synergistically induce apoptosis in non-small cell lung cancer cellsMYCN transgenic zebrafish model with the characterization of acute myeloid leukemia and altered hematopoiesis.Targeting glycolysis by 3-bromopyruvate improves tamoxifen cytotoxicity of breast cancer cell lines.Emerging metabolic targets in the therapy of hematological malignancies.Long-term prognostic implications and therapeutic target role of hexokinase II in patients with nasopharyngeal carcinomaResistance to chemotherapy is associated with altered glucose metabolism in acute myeloid leukemia.Control of amino acid transport coordinates metabolic reprogramming in T-cell malignancy.Autophagy and AML--food for thought.Critical roles of mTORC1 signaling and metabolic reprogramming for M-CSF-mediated myelopoiesis.2-Deoxy-D-glucose Restore Glucocorticoid Sensitivity in Acute Lymphoblastic Leukemia via Modification of N-Linked Glycosylation in an Oxygen Tension-Independent Manner.Over-expression of GAPDH in human colorectal carcinoma as a preferred target of 3-bromopyruvate propyl ester.3-Bromopyruvate antagonizes effects of lactate and pyruvate, synergizes with citrate and exerts novel anti-glioma effects.CXCL12 promotes glycolytic reprogramming in acute myeloid leukemia cells via the CXCR4/mTOR axis.Therapeutic Targeting of mTOR in T-Cell Acute Lymphoblastic Leukemia: An UpdateBiological Aspects of mTOR in Leukemia
P2860
Q26795759-CE7A1D05-A64E-465E-BBF2-9DCBFC0D4377Q26829652-E5799E17-E2BF-438C-9326-06954A3519C1Q28278236-EAD23B00-A8E2-4EF2-BFF9-AB97EF75A321Q28533798-02ABDAE4-467B-4D06-87E7-EFBF78BD085FQ34648675-FCFA715E-E3A5-45F1-B2E9-503F8124D653Q35829696-27951C92-5F3B-43E1-902E-E45DB9D3197BQ37137623-1B253481-BDAB-4CE8-87C2-0A4A41A8761CQ37225266-7F2C00F2-12AA-4DB1-B44E-79BA105129C9Q38761736-936EE3C0-135F-4AAA-B9EA-F3D092F2069EQ38762740-EFF20854-31AA-4815-A306-DA41A1CF76B3Q39739470-778F8710-885A-4A73-A744-EE27E99D8189Q40103297-84377FEF-042B-4EB1-AFF9-CACCCFC1FF28Q41320019-DFFB97F0-EC5F-4652-990D-FB60CB28EBB0Q42535968-30616EA2-1EA3-4D02-8438-37B085F75A11Q50253921-404100FD-517B-4222-BEC0-04ED654B15EAQ53154264-4083870E-35EE-430B-8EFD-5D9893E370AEQ56378380-2BD725ED-25AB-4C68-8D49-C5A0B3C3F1D2Q58780065-467EA462-EE30-49EF-88EB-885608F8E7DD
P2860
Targeting glycolysis in leukemia: a novel inhibitor 3-BrOP in combination with rapamycin
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Targeting glycolysis in leukemia: a novel inhibitor 3-BrOP in combination with rapamycin
@en
Targeting glycolysis in leukemia: a novel inhibitor 3-BrOP in combination with rapamycin.
@nl
type
label
Targeting glycolysis in leukemia: a novel inhibitor 3-BrOP in combination with rapamycin
@en
Targeting glycolysis in leukemia: a novel inhibitor 3-BrOP in combination with rapamycin.
@nl
prefLabel
Targeting glycolysis in leukemia: a novel inhibitor 3-BrOP in combination with rapamycin
@en
Targeting glycolysis in leukemia: a novel inhibitor 3-BrOP in combination with rapamycin.
@nl
P2093
P2860
P1433
P1476
Targeting glycolysis in leukemia: a novel inhibitor 3-BrOP in combination with rapamycin
@en
P2093
Alejandro G Levy
Anna R Franklin
Lauren J Akers
Peng Huang
Wendy Fang
P2860
P304
P356
10.1016/J.LEUKRES.2010.12.028
P577
2011-02-12T00:00:00Z